Retrograde Nerve-Sparing (NS) Laparoscopic Radical Prostatectomy (LRP): Technical Aspects and Early Results  Jens J. Rassweiler, Marto Sugiono, Marcel.

Slides:



Advertisements
Similar presentations
Pascal Rischmann  European Urology Supplements 
Advertisements

The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 65, Issue 3, Pages (March 2014)
Prostate Cancer: Highlights from 2006
Nerve-sparing Radical Cystectomy: A New Technique
Open Retropubic Nerve-Sparing Radical Prostatectomy
Hormone Therapy for Prostate Cancer: Exploring Current Controversies
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 51, Issue 2, Pages (February 2007)
Bladder Cancer: A Major Public Health Issue
Volume 53, Issue 5, Pages (May 2008)
Volume 49, Issue 1, Pages (January 2006)
Back to the Future: Introduction and Conclusions
Pitfalls of Pathologic Staging in Prostate Cancer
What is New in Hormone Therapy for Prostate Cancer in 2007?
Nerve-Sparing Open Radical Retropubic Prostatectomy
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Volume 65, Issue 3, Pages (March 2014)
Localised and Locally Advanced Prostate Cancer: Who to Treat and How?
Counselling the Prostate Cancer Patient
Robotic-Assisted Laparoscopic Radical Cystoprostatectomy
Laurent Boccon-Gibod  European Urology Supplements 
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Open versus Laparoscopic Radical Prostatectomy
Richard C. Harkaway  European Urology Supplements 
Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision  Hansjörg Keller, Joachim Lehmann, Jörn Beier 
Antonio Galfano, Silvia Secco, Aldo Massimo Bocciardi  European Urology 
Volume 50, Issue 5, Pages (November 2006)
Optimising Hormone Therapy in Advanced Disease
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Jens Rassweiler, Marcel Hruza, Jan Klein, Ali S. Goezen, Dogu Teber 
The Importance of Testosterone Control in Prostate Cancer
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006  Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,
Neal Shore  European Urology Supplements 
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Learning Curve of Laparoscopic Radical Prostatectomy in a University Teaching Hospital: Experience after the First 600 Cases  Luis Martínez-Piñeiro, Felipe.
Long-Term Hormonal Therapy: Who Would Benefit?
Sergio Bracarda  European Urology Supplements 
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Christian Stief  European Urology Supplements 
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Luis Martínez-Piñeiro  European Urology 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior  John Dean 
Axel Heidenreich  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Profile of Silodosin European Urology Supplements
Volume 52, Issue 1, Pages (July 2007)
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
Management of Prostate Cancer: Global Strategies
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Joaquim Bellmunt  European Urology Supplements 
The Impact of Premature Ejaculation on Partners and Relationships
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Epidemiology and Demographics of Prostatitis
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Axel Heidenreich  European Urology Supplements 
Volume 52, Issue 1, Pages (July 2007)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Retrograde Nerve-Sparing (NS) Laparoscopic Radical Prostatectomy (LRP): Technical Aspects and Early Results  Jens J. Rassweiler, Marto Sugiono, Marcel Hruza, Ahmet Tefekli, Christian Stock, Dogu Teber  European Urology Supplements  Volume 5, Issue 19, Pages 925-933 (November 2006) DOI: 10.1016/j.eursup.2006.07.010 Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 1 (A) Detaching NVB from apex of prostate. (B) Interfascial dissection between levator and prostatic fascia. (C) Clipping of small vessels medial to the right NVB. European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 2 Ligation of right prostate pedicle. European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 3 (A) Anterior retraction of the prostate reveals course of right NVB. (B) Course of NVBs after prostate entrapment. European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 4 Changes in frequency of the nerve-sparing approach (n=1500). European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 5 Proportion of clinically localised (T1+T2) versus locally advanced (T3+T4) tumours (n=1500). European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 6 Distribution of pathologically confirmed localised (pT2) versus locally advanced (pT3–T4) tumours with time (n=1500). European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 7 Overall positive margin status with increasing experience (n=1500). European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 8 Percentage of patients of all ages after non-NS, unilateral NS, or bilateral NS procedures who were able to have penetrative intercourse when using different erectile aids. NS=nerve-sparing; +/−=with or without; PDE5=phosphodiesterase type 5; Inh=inhibitor. European Urology Supplements 2006 5, 925-933DOI: (10.1016/j.eursup.2006.07.010) Copyright © 2006 European Association of Urology Terms and Conditions